Insurance coverage for GLPs vary widely, with some covering it for weight loss and others barely covering it for diabetes and only certain types
The GLP-1 class has its own specific rules some shared across all medications in the class, some unique to semaglutide or tirzepatide specifically
Incidences of other toxicities were comparable across the three treatment groups in DURATION-8 (exenatide plus dapagliflozin, exenatide alone, and dapagliflozin alone, respectively), including pancreatitis (1.3%, 0.4%, and 0%), volume depletion (1.3%, 0.4%, and 2.1%), gastrointestinal events (20.8%, 23.9%, and 16.3%), and genital infections (5.2%, 2.2%, and 7.7%) [36]
In vivo, it is not actually going to bind to albumin, but [the glycan] has sialic acid moieties, which also reduces the liver metabolism, and thus increases the circulating half-life in the blood, explains Melbourne researcher Chaitra Chandrashekar, who carried out the work
The new medication, a daily oral GLP-1 pill called orforglipron, which can promote weight loss in adults with obesity, demonstrates additional potential for adults who have both obesity and Type 2 diabetes
